Category: Biolinerx

ISIS NBY BLRX IMMU SSH - Investor Relations Responses Posted

05/03/2013

A new set of recent investor relations (IR) questions and responses from biotechs provided by Mike O'Neill has been posted, covering financials and upcoming catalysts for each biotech stock.

This round of responses features Isis Pharmaceuticals $ISIS, NovaBay Pharmaceuticals $NBY, BioLineRx $BLRX, Immunomedics $IMMU, and Sunshine Heart Inc $SSH.

Check out the complete index of all IR Questions and Answers if you missed the previous editions - now covering >70 biotech and pharmaceutical companies!

10/10/2011

I don't yet cover BLRX with a complete page on BiotechDueDiligence, nor do I own the stock currently. But I am interested in the company, so I'll share my notes from their webcast at the UBS conference.
See the Upcoming Events page for a complete list of biotech webcast, catalysts, and presentations plus links to my notes.
See my notes from the webcast below: